One pill vs. two: new combo drug may simplify diabetes care
NCT ID NCT06327815
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study tested whether a single pill containing two diabetes drugs (dapagliflozin and metformin) works as well as taking them separately in Chinese adults with type 2 diabetes. Over 600 participants took either the combo pill or the two separate pills for 24 weeks. The main goal was to see if blood sugar control was similar between groups. This is a disease control study, not a cure, as diabetes requires ongoing management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Beijing, 100020, China
-
Research Site
Beijing, 100050, China
-
Research Site
Beijing, 100076, China
-
Research Site
Beijing, 102218, China
-
Research Site
Changsha, 410005, China
-
Research Site
Chengdu, 610072, China
-
Research Site
Chongqing, 402260, China
-
Research Site
Chuxiong, 675000, China
-
Research Site
Dalian, 116001, China
-
Research Site
Dingzhou, 562100, China
-
Research Site
Fuyang, 236400, China
-
Research Site
Guangzhou, 510180, China
-
Research Site
Guangzhou, 510515, China
-
Research Site
Guiyang, 550044, China
-
Research Site
Hefei, 230012, China
-
Research Site
Jiangyin, 214400, China
-
Research Site
Jiyuan, 459003, China
-
Research Site
Kunming, 650032, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanning, China
-
Research Site
Nantong, 226001, China
-
Research Site
Panjin, 124000, China
-
Research Site
Qingdao, 266200, China
-
Research Site
Quanzhou, 362000, China
-
Research Site
Rui’an, 325200, China
-
Research Site
Shenzhen, 518101, China
-
Research Site
Suzhou, 215500, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Tianjin, 300134, China
-
Research Site
Weifang, 261035, China
-
Research Site
Wenzhou, 325000, China
-
Research Site
Wuhan, 430010, China
-
Research Site
Yibin, 610500, China
-
Research Site
Zhengzhou, 450052, China
-
Research Site
Zhuji, 311899, China
Conditions
Explore the condition pages connected to this study.